The present disclosure relates to patient support apparatuses, such as hospital beds, for example, which include active support surfaces. More specifically, the present disclosure relates to patient support apparatuses that provide an air fluidized therapy.
Air fluidized therapy provides minimal shear and frictional force to the skin of a patient occupying the hospital bed. Reducing shear and frictional forces between the patient and the bed improves healing conditions when a patient is recovering from skin trauma. As an example, skin trauma may be caused by burns as well as skin grafts performed as surgical treatment for the burns.
Air fluidized therapy may be periodically stopped such that the bed no longer provides the desired support for improving healing conditions. For example, the air fluidized therapy may be stopped when the patient exits the bed or while a second therapy is performed. The patient or a caregiver of the patient may forget to initiate the air fluidized therapy after the patient returns to bed or after the second therapy ends.
The present application discloses one or more of the features recited in the appended claims and/or the following features which, alone or in any combination, may comprise patentable subject matter:
According to a first aspect of the present disclosure, an air fluidization therapy bed may comprise a fluidization system, a tank assembly, a head end support assembly, and a quick release handle. The tank assembly may include a fluidization space and a fluidizable medium positioned in the fluidization space. The tank assembly may be configured to receive a flow of pressurized air from the fluidization system to fluidize the fluidizable medium to cause the tank assembly to provide air fluidized therapy to a patient supported on the air fluidization therapy bed. The head end support assembly may include a plurality of inflatable bladders. The head end support assembly may be configured to variably incline relative to the tank assembly. The quick release handle may be configured to cause the head end support assembly to rapidly lower into a horizontal position and to instruct the fluidization system to draw down at least one of the plurality of inflatable bladders when the quick release handle is activated.
In some embodiments, the air fluidization therapy bed may further include a controller configured to instruct fluidization system to stop the air fluidized therapy when the quick release handle is activated. In some embodiments, the fluidization system may be configured to draw down each of the plurality of inflatable bladders when the quick release handle is activated.
In some embodiments, the air fluidization therapy bed may further include a control interface configured to allow a user to initiate and stop the air fluidized therapy. The controller may be configured to instruct the control interface to display a notification informing the user that the air fluidization therapy has been stopped for a predetermined amount of time after the predetermined amount of time has elapsed.
In some embodiments, the air fluidization therapy bed may further include a control interface configured to allow a user to initiate and stop the air fluidized therapy and a controller. The controller may be configured to instruct the control interface to display a notification informing the user that the air fluidization therapy has been stopped for a predetermined amount of time after the predetermined amount of time has elapsed.
In some embodiments, the predetermined amount of time may be about 30 minutes. In some embodiments, the air fluidization therapy bed may further include a controller configured to instruct the fluidization system to stop the air fluidized therapy when the quick release handle is activated.
In some embodiments, the controller may be further configured to detect if a patient is supported on the air fluidization therapy bed. The controller may instruct the control interface to display the notification only if a patient is detected.
According to another aspect of the present disclosure a method of operating an air fluidization therapy bed may include reclining a head end support assembly included in the air fluidization therapy bed relative to a tank assembly in response to a quick release handle being pulled, the tank assembly including a fluidization space and a fluidizable medium positioned in the fluidization space and the head end support assembly having a plurality of inflatable bladders, the tank assembly configured to provide air fluidized therapy to a patient supported on the air fluidization therapy bed, and the head end support assembly configured to variably incline relative to the tank assembly; and drawing down with a vacuum the plurality of inflatable bladders included in the head end support assembly in response to the quick release handle being pulled.
In some embodiments, the method may further include stopping air fluidization therapy being provided by the air fluidization therapy bed in response to the quick release handle being pulled. In some embodiments, the method may further include displaying a notification screen on a graphical interface that the air fluidization therapy has been stopped for a predetermined amount of time after the predetermined amount of time has passed. In some embodiments, the notification screen may include an option to turn on the air fluidization therapy.
In some embodiments, reclining the head end support assembly and drawing down the inflatable bladders may cause an upper body portion of the patient to have less than a 10 degree incline relative to a lower body portion of the patient. In some embodiments, drawing down with a vacuum the plurality of inflatable bladders may completely deflate the plurality of inflatable bladders.
According to another aspect of the present disclosure, an air fluidization therapy bed may comprise a tank assembly, a control interface, and a controller. The assembly may include a fluidization space and a fluidizable medium positioned in the fluidization space. The tank assembly may be configured to receive a flow of pressurized air from an air supply to fluidize the fluidizable medium to cause the tank assembly to provide air fluidized therapy to a patient supported on the air fluidization therapy bed. The control interface may be configured to allow a user to initiate and stop the air fluidized therapy. The controller may be configured to instruct the control interface to display a notification informing the user that the air fluidization therapy has been stopped for a predetermined amount of time after the air fluidization therapy has been stopped for the predetermined amount of time.
In some embodiments, the predetermined amount of time may be about 30 minutes. In some embodiments, the air fluidization therapy bed may further include a head section that includes a plurality of inflatable support bladders. The head section may be configured to variably incline relative to the tank assembly.
In some embodiments, the controller may be further configured to detect if a patient is supported on the air fluidization therapy bed. The controller may instruct the control interface to display the notification only if a patient is detected.
According to another aspect of the present disclosure a method of operating an air fluidization therapy bed may include stopping an air fluidization therapy provided by the air fluidization therapy bed, the air fluidization therapy bed comprising a tank assembly including a fluidization space and a fluidizable medium positioned in the fluidization space, the tank assembly configured to receive a flow of pressurized air to fluidize the fluidizable medium to cause the tank assembly to provide air fluidized therapy to a patient supported on the air fluidization therapy bed; and displaying a notification screen on a control interface included in the air fluidization therapy bed that the air fluidization therapy has been stopped for a predetermined amount of time after the predetermined amount of time has passed.
In some embodiments, the notification screen may include an option to turn on the air fluidization therapy.
Additional features, which alone or in combination with any other feature(s), including those listed above and those listed in the claims, may comprise patentable subject matter and will become apparent to those skilled in the art upon consideration of the following detailed description of illustrative embodiments exemplifying the best mode of carrying out the invention as presently perceived.
The detailed description particularly refers to the accompanying figures in which:
An illustrative patient support apparatus 10 is shown in
In the illustrative embodiment, air fluidization bed 12 includes a fluidization system 26, a tank assembly 16, a head end support assembly 18, and a quick release handle 90 as shown in
Illustratively, patient support apparatus 10 further includes a control interface 76 and a controller 70. Control interface 76 is configured to allow a user to initiate and stop the air fluidized therapy as shown in
Air fluidization bed 12 illustratively includes tank assembly 16, head end support assembly 18, and fluidization system 26 as shown in
Carriage 14 is configured to support air fluidization bed 12 and includes a lower frame 28, an upper frame 30, and a support system 32 supporting upper frame 30 on lower frame 28. In one illustrative embodiment, support system 32 includes a lift system 32 actuated by a Hi/Lo actuator 34 configured to cause lift system 32 to raise and/or lower upper frame 30 with respect to lower frame 28. In illustrative embodiments, lower frame 28 is supported by casters 38 to help with transport of patient support apparatus 10.
Upper frame 30 supports air fluidization bed 12 as shown in
Air fluidization bed 12 illustratively includes tank assembly 16, head end support assembly 18, and fluidization system 26 as shown in
Tank assembly 16 includes a tank base 44, a tank liner 46, a tank bladder 48, and a filter sheet 50 as shown in
Tank base 44 is coupled to upper frame 30 by tank fasteners (not shown) and includes an inlet 60 that couples to fluidization system 26. Tank liner 46 and tank bladder 48 are coupled together to form the sides of tank assembly 16. Tank base 44, tank liner 46, tank bladder 48, and filter sheet 50 cooperate to define space 22 therebetween that contains fluidizable medium 24.
Filter sheet 50 is configured to allow fluid, such as, bodily fluids and air, to pass therethrough while preventing fluidizable medium 24 from passing through. Filter sheet 50 is also configured to provide sufficient support to minimize or eliminating hammocking from occurring when a patient is supported by fluidized fluidizable medium 24 so that the patient is properly supported. Filter sheet 50 is positioned over space 22 and is coupled to tank liner 46 as shown in
Tank assembly 16 further includes a diffuser 52 configured to support fluidizable medium 24 thereon and provide substantially uniform fluid flow to fluidizable medium 24 from fluidization system 26 as suggested, for example, in
Head end support assembly 18 includes a person support surface 54 or mattress 54 composed of fluid bladders 56 (sometimes called inflatable bladders) in the illustrative embodiment. Fluid bladders 56 are configured to be inflated, such as with air, to a pressure which is optimized to reduce the incidence of the development of decubitus ulcers, also known as bedsores.
In the embodiment shown in
Referring now to
Fluidization system 26 includes a variable speed blower 62 that is operable to vary the volume of air flowing into inlet 60. In the illustrative embodiment, fluidization system 26 further includes a pump 64 configured to inflate bladders 56 and to apply a vacuum to fluid bladders 56 to draw down fluid bladders 56 by application of vacuum or negative pressure. As an example, pump 64 is configured to draw down fluid bladders 56 and other fluid bladders included in patient support apparatus 10 when a patient is exiting patient support apparatus 10. As shown in
Patient support apparatus 10 further includes a controller 70 that operates fluidization system 26 as shown in
In addition, patient support apparatus 10 includes control interface 76 that includes a display 78 and a plurality of user inputs 80 that are operable to change the operation of patient support apparatus 10 as shown in
Air fluidization bed 12 is configured to provide air fluidization therapy to a patient supported on patient support apparatus 10. Air fluidized therapy may be stopped such that air fluidization bed 12 no longer provides the desired support for improving healing conditions. For example, air fluidized therapy may be stopped when the patient is exiting air fluidization bed 12 or while a second therapy is performed. Air fluidization therapy may be stopped intentionally or unintentionally for a plurality of reasons. The patient or a caregiver of the patient may forget to re-initiate the air fluidized therapy after the patient returns to air fluidization bed 12 or after the second therapy ends.
Controller 70 is configured to instruct control interface 76 to display a notification screen 82 informing the user or caregiver that air fluidization therapy has been stopped for a predetermined amount of time after the predetermined amount of time has elapsed as shown in
In the illustrative example, the notification displayed on notification screen 82 states “Bed Therapy has been turned off for more than 30 minutes.” “Continue” and “Cancel” buttons or icons are also shown on notification screen 82 as shown in
In some embodiments, patient support apparatus 10 is connected with a hospital network (not shown). Controller 70 may be configured to send the notification and other information relating to the air fluidized therapy to a nurse call station, remote computer, etc. In some embodiments, patient support apparatus 10 has a wired connection with the hospital network. In other embodiments, patient support apparatus 10 has a wireless connection with the hospital network.
Patient support apparatus 10 further includes quick release handle 90 as shown in
In the illustrative embodiment, controller 70 stops air fluidized therapy when quick release handle 90 is pulled. If air fluidized therapy is not re-initiated after quick release handle 90 is pulled, control interface 76 will display notification screen 82, as discussed above, informing the user or caregiver that air fluidization therapy has been stopped for the predetermined amount of time after the predetermined amount of time has elapsed.
Illustratively, pump 64 is instructed or controlled to apply a vacuum to fluid bladders 56 included in head end support assembly 18 to draw down fluid bladders 56 when quick release handle 90 is pulled. In the illustrative embodiment, fluid bladders 56 are drawn down to head deck section 42 when quick release handle 90 is pulled. In other embodiments, fluid bladders 56 are drawn down as far as possible, such as down to a foam base layer situated beneath bladders 56, when quick release handle 90 is pulled.
The patient's lower body is partially immersed in fluidizable medium 24 when air fluidized therapy is stopped as suggested in
Although certain illustrative embodiments have been described in detail above, variations and modifications exist within the scope and spirit of this disclosure as described and as defined in the following claims.
The present application claims the benefit, under 35 U.S.C. §119(e), of U.S. Provisional Application No. 62/236,320, filed Oct. 2, 2015, and which is hereby incorporated by reference herein in its entirety.
Number | Date | Country | |
---|---|---|---|
62236320 | Oct 2015 | US |